SMARCB1 and cancer: Given the discordance of our in vitro studies on the recurrent R377H mutation and the fact that these computational tools predict pathogenic effects broadly outside a cancer-specific context, we sought to investigate the functional effects of all possible missense mutations in SMARCB1 using DMS.